Targeting gold at the end of the rainbow: Surgical gamma probes in the 21st century

Frederick L. Moffat

doi:10.1002/jso.20861

Targeting gold at the end of the rainbow: Surgical gamma probes in the 21st century

Frederick L. Moffat

Surgery

Research output: Contribution to journal › Review article

6 Scopus citations

Abstract

Surgical gamma detection probes (GDPs) have become important in the surgical management of neoplastic disease in the past 20 years. Their history and radiophysics are discussed, with consideration of the overarching issue of tumor-to-background ratio (TBR). GDPs are currently most commonly used in sentinel node applications in a variety of tumors. Whether their role in clinical surgical practice can be extended to other applications will depend on the development of radiolabeled tumor marking agents which have much improved TBR, and parallel developments in oncology research which may overtake this technology.

Original language	English (US)
Pages (from-to)	286-289
Number of pages	4
Journal	Journal of surgical oncology
Volume	96
Issue number	4
DOIs	https://doi.org/10.1002/jso.20861
State	Published - Sep 15 2007

Keywords

Radioimmunoguided surgery
Sentinel node biopsy
Tumor-to background ratio

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1002/jso.20861

Fingerprint Dive into the research topics of 'Targeting gold at the end of the rainbow: Surgical gamma probes in the 21st century'. Together they form a unique fingerprint.

Cite this

Moffat, F. L. (2007). Targeting gold at the end of the rainbow: Surgical gamma probes in the 21st century. Journal of surgical oncology, 96(4), 286-289. https://doi.org/10.1002/jso.20861

@article{6468196282c84fcb840e03d805c012b7,

title = "Targeting gold at the end of the rainbow: Surgical gamma probes in the 21st century",

abstract = "Surgical gamma detection probes (GDPs) have become important in the surgical management of neoplastic disease in the past 20 years. Their history and radiophysics are discussed, with consideration of the overarching issue of tumor-to-background ratio (TBR). GDPs are currently most commonly used in sentinel node applications in a variety of tumors. Whether their role in clinical surgical practice can be extended to other applications will depend on the development of radiolabeled tumor marking agents which have much improved TBR, and parallel developments in oncology research which may overtake this technology.",

keywords = "Radioimmunoguided surgery, Sentinel node biopsy, Tumor-to background ratio",

author = "Moffat, {Frederick L.}",

year = "2007",

month = sep,

day = "15",

doi = "10.1002/jso.20861",

language = "English (US)",

volume = "96",

pages = "286--289",

journal = "Journal of Surgical Oncology",

issn = "0022-4790",

publisher = "Wiley-Liss Inc.",

number = "4",

}

TY - JOUR

T1 - Targeting gold at the end of the rainbow

T2 - Surgical gamma probes in the 21st century

AU - Moffat, Frederick L.

PY - 2007/9/15

Y1 - 2007/9/15

N2 - Surgical gamma detection probes (GDPs) have become important in the surgical management of neoplastic disease in the past 20 years. Their history and radiophysics are discussed, with consideration of the overarching issue of tumor-to-background ratio (TBR). GDPs are currently most commonly used in sentinel node applications in a variety of tumors. Whether their role in clinical surgical practice can be extended to other applications will depend on the development of radiolabeled tumor marking agents which have much improved TBR, and parallel developments in oncology research which may overtake this technology.

AB - Surgical gamma detection probes (GDPs) have become important in the surgical management of neoplastic disease in the past 20 years. Their history and radiophysics are discussed, with consideration of the overarching issue of tumor-to-background ratio (TBR). GDPs are currently most commonly used in sentinel node applications in a variety of tumors. Whether their role in clinical surgical practice can be extended to other applications will depend on the development of radiolabeled tumor marking agents which have much improved TBR, and parallel developments in oncology research which may overtake this technology.

KW - Radioimmunoguided surgery

KW - Sentinel node biopsy

KW - Tumor-to background ratio

UR - http://www.scopus.com/inward/record.url?scp=34848850435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848850435&partnerID=8YFLogxK

U2 - 10.1002/jso.20861

DO - 10.1002/jso.20861

M3 - Review article

C2 - 17726662

AN - SCOPUS:34848850435

VL - 96

SP - 286

EP - 289

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 4

ER -